GreenNanoBone Challenge
As cancer survival rates improve and antiresorptive therapies become more common, cases of Medication-Related Osteonecrosis of the Jaw (MRONJ) are rising. Current treatment options are limited, often focussed on symptom management and frequently rely on long-term antibiotics. This not only contributes to antimicrobial resistance but also significantly impacts a patient's quality of life. There's a clear need for new, minimally invasive treatments that can regenerate tissue and address the root cause of MRONJ, rather than just its symptoms.
GreenNanoBone addresses this gap. It focuses on preventing MRONJ and promoting tissue regeneration using smart, bioactive and antimicrobial materials. The project’s approach is deeply sustainable: GreenNanoBone transforms agricultural and industrial waste into valuable resources, linking therapeutic innovation with the broader societal goal of reducing healthcare's environmental footprint.



